“…CBD has been considered as a potential therapeutic agent since the 1970s, when its anti-seizure properties were first examined in animal studies. A few very small randomized clinical trials were also conducted in adults with epilepsy, some showing positive results. But what has generated the renewed interest and excitement are the anecdotal reports that some children with otherwise untreatable severe epilepsies respond well to CBD extracts and oils (please see Porter & Jacobson 2013; Hussain et al. 2015)”
Editor’s note: An interesting article written by Nora Volkow, Director of the National Institute on Drug Abuse (NIDA). She discusses how the strict regulations on medical research of Schedule I substances have made it difficult to learn more about the chemicals found in marijuana, and how she hopes to change that.